Article info

Download PDFPDF
Comment on l’Ami et al titled ’Successful reduction of overexposure in patients with rheumatoid arthritis with high serum adalimumab concentrations: an open-label, non-inferiority, randomised clinical trial'

Authors

  1. Correspondence to Dr Alfons A den Broeder, Reumatologie, Sint Maartenskliniek, Nijmegen, 6522 JV, Netherlands; a.denbroeder{at}maartenskliniek.nl
View Full Text

Citation

den Broeder AA, van den Bemt BJF
Comment on l’Ami et al titled ’Successful reduction of overexposure in patients with rheumatoid arthritis with high serum adalimumab concentrations: an open-label, non-inferiority, randomised clinical trial'

Publication history

  • Received October 23, 2017
  • Accepted October 25, 2017
  • First published November 1, 2017.
Online issue publication 
September 12, 2018

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.